 Connection
Joshua Wisell to Biomarkers, Tumor
This is a "connection" page, showing publications Joshua Wisell has written about Biomarkers, Tumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.449 |
|
|
|
-
Wisell J, Kleinschmidt-DeMasters BK. Sox10 nuclear immunostaining lacks diagnostic utility for CNS granular cell tumors. J Neuropathol Exp Neurol. 2014 Jan; 73(1):98-100.
Score: 0.293
-
Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res. 2017 06; 27(3):189-199.
Score: 0.093
-
Hristov AC, Wisell J. A "high-risk" epithelioid hemangioendothelioma presenting as a solitary, ulcerated, subcutaneous tumor. Am J Dermatopathol. 2011 Dec; 33(8):e88-90.
Score: 0.063
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|